BenzingaOctober 14, 2026 at 9:28 AM NY13 Days Ago
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $51.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
